Jingbin Zhong
Overview
Explore the profile of Jingbin Zhong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun W, Li J, Zhong J, Feng J, Ye Z, Lin Y, et al.
Nanomedicine (Lond)
. 2024 Sep;
19(27):2301-2314.
PMID: 39310995
In this study, we evaluated the effects of two types of hydroxyapatite (HAP) nanoparticles, sharing the same surface chemistry but differing in shape, on the biological characteristics of plasma, platelets...
2.
Sun W, Zhong J, Gao B, Feng J, Ye Z, Lin Y, et al.
Int J Nanomedicine
. 2024 Aug;
19:8661-8679.
PMID: 39193530
Purpose: Hydroxyapatite-based nanoparticles have found diverse applications in drug delivery, gene carriers, diagnostics, bioimaging and tissue engineering, owing to their ability to easily enter the bloodstream and target specific sites....
3.
Ling X, Peng S, Zhong J, Guo L, Xu Y, Jin X, et al.
Front Pharmacol
. 2022 May;
13:778032.
PMID: 35614949
Chang-Kang-Fang formula (CKF), a multi-herb traditional Chinese medicine, has been used in clinical settings to treat irritable bowel syndrome (IBS). Recent studies show that 5.0 g/kg/d CKF can alleviate the...
4.
Tao H, Zhong J, Mo Y, Liu W, Wang H
Evid Based Complement Alternat Med
. 2022 Apr;
2022:9748338.
PMID: 35449811
Increased uric acid levels and inflammatory reactions are the main factors considered responsible for the development of gouty arthritis. L. (PEL) has several promising pharmacological properties, including anti-inflammation and antioxidation....